A functional polymorphism in the promoter region of the IL1B gene is associated with risk of multiple myeloma

British Journal of Haematology

Volumn 158, Issue 4, 2012, Pages 515-518

  Vangsted, Annette J ^a   Nielsen, Kaspar R ^b   Klausen, Tobias W ^c   Haukaas, Einar ^d   Tjønneland, Anne ^e   Vogel, Ulla ^f  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d Department of Hematology   (Norway)

^e INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^f NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

Author keywords

IL1B; Multiple myeloma; NFKB1; Polymorphism

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADAPTIVE IMMUNITY; ARTICLE; BINDING SITE; CANCER IMMUNOLOGY; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IL1B GENE; INNATE IMMUNITY; MULTIPLE MYELOMA; NFKB1 GENE; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECRETION; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-1BETA; MALE; MULTIPLE MYELOMA; NF-KAPPA B P50 SUBUNIT; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84864321696     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09141.x     Document Type: Article

References (15)

1. Alexander, D.D., Mink, P.J., Adami, H.O., Cole, P., Mandel, J.S., Oken, M.M. & Trichopoulos, D. (2007) Multiple myeloma: a review of the epidemiologic literature. International Journal of Cancer, 120(Suppl. 12), 40-61.
2. Chen, H., Wilkins, L.M., Aziz, N., Cannings, C., Wyllie, D.H., Bingle, C., Rogus, J., Beck, J.D., Offenbacher, S., Cork, M.J., Rafie-Kolpin, M., Hsieh, C.M., Kornman, K.S. & Duff, G.W. (2006) Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Human Molecular Genetics, 15, 519-529.
3. Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., Perfettini, J.L., Schlemmer, F., Tasdemir, E., Uhl, M., Genin, P., Civas, A., Ryffel, B., Kanellopoulos, J., Tschopp, J., Andre, F., Lidereau, R., McLaughlin, N.M., Haynes, N.M., Smyth, M.J., Kroemer, G. & Zitvogel, L. (2009) Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nature Medicine, 15, 1170-1178.
4. Haabeth, O.A., Lorvik, K.B., Hammarstrom, C., Donaldson, I.M., Haraldsen, G., Bogen, B. & Corthay, A. (2011) Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer. Nature Communications, 2, 240.
5. Karban, A.S., Okazaki, T., Panhuysen, C.I., Gallegos, T., Potter, J.J., Bailey-Wilson, J.E., Silverberg, M.S., Duerr, R.H., Cho, J.H., Gregersen, P.K., Wu, Y., Achkar, J.P., Dassopoulos, T., Mezey, E., Bayless, T.M., Nouvet, F.J. & Brant, S.R. (2004) Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Human Molecular Genetics, 13, 35-45.
6. Karin, M. (2006) Nuclear factor-kappaB in cancer development and progression. Nature, 441, 431-436.
7. Lacy, M.Q., Donovan, K.A., Heimbach, J.K., Ahmann, G.J. & Lust, J.A. (1999) Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma. Blood, 93, 300-305.
8. Landgren, O., Kristinsson, S.Y., Goldin, L.R., Caporaso, N.E., Blimark, C., Mellqvist, U.H., Wahlin, A., Bjorkholm, M. & Turesson, I. (2009) Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden. Blood, 114, 791-795.
9. O'Neill, L.A. (2008) The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunological Reviews, 226, 10-18.
10. Vangsted, A.J., Klausen, T.W., Ruminski, W., Gimsing, P., Andersen, N.F., Gang, A.O., Abildgaard, N., Knudsen, L.M., Nielsen, J.L., Gregersen, H. & Vogel, U. (2009) The polymorphism IL-1beta T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT. Bone Marrow Transplantation, 43, 539-545.
11. Vangsted, A.J., Klausen, T.W., Abildgaard, N., Andersen, N.F., Gimsing, P., Gregersen, H., Nexo, B.A. & Vogel, U. (2011) Single nucleotide polymorphisms in the promoter region of the IL1B gene influence outcome in multiple myeloma patients treated with high-dose chemotherapy independently of relapse treatment with thalidomide and bortezomib. Annals of Hematology, 90, 1173-1181.
12. Vangsted, A., Klausen, T.W. & Vogel, U. (2012) Genetic variations in multiple myeloma I: effect on risk of multiple myeloma. European Journal of Haematology, 88, 8-30.
13. Vogel, U., Christensen, J., Dybdahl, M., Friis, S., Hansen, R.D., Wallin, H., Nexo, B.A., Raaschou-Nielsen, O., Andersen, P.S., Overvad, K. & Tjonneland, A. (2007) Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. Mutation Research, 624, 88-100.
14. Vogel, U., Jensen, M.K., Due, K.M., Rimm, E.B., Wallin, H., Nielsen, M.R., Pedersen, A.P., Tjonneland, A. & Overvad, K. (2011) The NFKB1 ATTG ins/del polymorphism and risk of coronary heart disease in three independent populations. Atherosclerosis, 219, 200-204.
15. Xiong, Y., Donovan, K.A., Kline, M.P., Gornet, M.K., Moon-Tasson, L.L., Lacy, M.Q., Dispenzieri, A., Gertz, M.A., Greipp, P.R. & Lust, J.A. (2006) Identification of two groups of smoldering multiple myeloma patients who are either high or low producers of interleukin-1. Journal of Interferon & Cytokine Research, 26, 83-95.